Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) Target Price at $81.10

Henry Schein, Inc. (NASDAQ:HSIC) has been given a consensus rating of “Moderate Buy” by the eleven brokerages that are currently covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $81.10.

A number of equities analysts have commented on HSIC shares. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Finally, Mizuho started coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company.

Insider Activity at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Henry Schein

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Olstein Capital Management L.P. raised its stake in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after buying an additional 16,000 shares during the period. Private Management Group Inc. increased its stake in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after buying an additional 18,882 shares in the last quarter. Equitable Trust Co. purchased a new position in shares of Henry Schein in the fourth quarter valued at approximately $417,000. Savant Capital LLC grew its stake in Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock valued at $322,000 after acquiring an additional 1,420 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock valued at $1,113,000 after acquiring an additional 3,650 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Price Performance

Shares of HSIC opened at $68.62 on Thursday. The business’s 50-day moving average is $74.62 and its 200-day moving average is $72.64. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a market capitalization of $8.52 billion, a price-to-earnings ratio of 28.24, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.66 earnings per share. Equities research analysts expect that Henry Schein will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.